<DOC>
	<DOCNO>NCT02029703</DOCNO>
	<brief_summary>The study hypothesis use Synvisc-One improve physical therapy compliance performance , result improve knee function pain compare group receive sham injection ( injection medicine ) standardize physical therapy regimen 10 week .</brief_summary>
	<brief_title>Optimization Synvisc-One Knee OA</brief_title>
	<detailed_description>This prospective , randomize , double-blind ( subject physical therapist ) , sham needle injection control , single center , multi-site study . Subjects primary osteoarthritis knee pain randomly assign 6 ml intra-articular injection Synvisc-One sham needle injection . The post-treatment course physical therapy begin Day 3 Day 14 last 12 week duration ( PT end study Week 12 ) . Subjects encourage complete 6 16 physical therapy visit within 10-12 week physical therapy treatment determine treat Physical Therapist .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male female subject meet American College Rheumatology ( ACR ) criteria primary knee OA age 21 great radiographic symptomatic evidence tibiofemoral OA 6 month ( unilateral , single joint , KellgrenLawrence Grading Scale Score 2 3 , medial lateral +/ patellofemoral ) . Subjects persistent target knee OA pain despite treatment ≥ 3 month acetaminophen 4 gram less OA pain treatment . Subjects willing discontinue prohibit treatment medication ( e.g . opioids , narcotic analgesic , Tramadol ) throughout study period . Subjects currently prescription strength NSAIDs ( Non steroidal antiinflammatory drug ) must maintain stable regimen ( dose increase new analgesic ) entire study period . Female subject child bear potential must negative serum urine pregnancy test prior SynviscOne® sham injection . Female subject child bear potential must agree use medically acceptable form contraception least 1 month prior SynviscOne® sham injection must agree continue use acceptable form contraception duration study . Otherwise , females must surgically sterile , postmenopausal document medical history least 1 year . Subjects willing able commit standard 10 week course physical therapy . Subjects willing able sign write informed consent . KellgrenLawrence Grading Scale score Grade 1 Grade 4 give low efficacy viscosupplements population KOOS validate patient population . Known allergy hylan GF 20 component , avian protein , egg , feather , , poultry . History viscosupplementation target knee joint within 3 month baseline visit . Isolated patellofemoral OA isolate anterior knee pain ( patellofemoral OA coexist tibiofemoral knee OA may include ) . Symptomatic bilateral knee OA ( unless contralateral knee involvement limit radiographic OA symptomatic ) . Ipsilateral symptomatic OA hip ankle ; contralateral symptomatic OA hip , knee , ankle , clinical evidence hip disease . Clinically apparent knee joint infection , tense effusion acute inflammation target knee baseline . History septic OA joint ; / Inflammatory arthropathy RA ( Rheumatoid Arthritis ) , gout , pseudogout , lupus , crystalline inflammatory arthropathy , chondrocalcinosis etc . Active infection lower extremity ( e.g . cellulitis ) . Prosthetic implant either knee . Subjects clinical indication arthroscopic surgery . Subjects plan schedule surgery course study ( schedule await arthroscopy knee replacement procedure OA knee ) . Subjects plan initiate cease OA treatment include , limited non pharmacologic , pharmacologic , surgical , chiropractic , acupuncture course study . Subjects plan initiate , cease continue intraarticular knee joint injection course study . History systemic and/or intraarticular steroid injection target knee within one month prior baseline visit . History open knee surgery affect knee history arthroscopic surgery affect knee past year . History complete menisectomy . Suspected meniscus injury , include positive McMuray 's test significant joint line tenderness . Cruciate / collateral knee ligament instability , ligament laxity , meniscal instability target knee . Obvious cartilage defect produce mechanical symptom ( i.e . lock ) . Patellar tendonitis . Significant alignment deformity varus / valgus target knee judgment investigator . Venous lymphatic stasis either leg . Past current history peripheral vascular disease pertain involve limb . Concurrent multisystem multilimb trauma . Known significant acute / concurrent medical comorbidities include , limited current malignancy , history transplant surgery , congestive heart failure , significant unstable cardiovascular disease , renal , hepatic , pulmonary , endocrine , metabolic , gastrointestinal , neurological condition judgment investigator would significantly impact life expectancy / conduct trial . Known psychiatric disorder . Body mass index ( BMI ) &gt; 40 . Female subject interested conceive child study period . Currently pregnant new mother breastfeed . Subjects currently prescribe chronic opioid analgesic time baseline visit discontinue . Use prohibit pain medication . Any known contraindication acetaminophen . Subjects currently enrol experimental clinical trial history trial enrollment within three month baseline . Subjects plan move relocate area inhibit ability complete entire physical therapy regimen define protocol prescribe investigator . Knee pain associate Worker 's Compensation Claim .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Knee Osteoarthritis</keyword>
	<keyword>Knee Pain</keyword>
	<keyword>Synvisc-One</keyword>
</DOC>